Loading…

Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review

Purpose To study the interaction between benign prostatic hyperplasia (BPH) and prostate cancer (PCa). Methods In this study, we performed a chart review of a cohort of 448 biopsy naive men. These men received a multi-core biopsy at our institution due to increased prostate-specific antigen (PSA) se...

Full description

Saved in:
Bibliographic Details
Published in:International urology and nephrology 2016-01, Vol.48 (1), p.91-97
Main Authors: Al-Khalil, Shadi, Boothe, David, Durdin, Trey, Sunkara, Sowmya, Watkins, Phillip, Yang, Shengping, Haynes, Allan, de Riese, Werner
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To study the interaction between benign prostatic hyperplasia (BPH) and prostate cancer (PCa). Methods In this study, we performed a chart review of a cohort of 448 biopsy naive men. These men received a multi-core biopsy at our institution due to increased prostate-specific antigen (PSA) serum levels (>4 ng/ml) and/or suspicious findings on digital rectal examination in the years between 2008 and 2013. Utilizing PSA and transrectal ultrasound (TRUS) prostate volume, we obtained the PSA density (PSAD) for each individual. PSAD was calculated by dividing serum PSA concentration by TRUS prostate volume. Results Large prostates >65 g may secrete enough PSA to have a PSAD above the suggested cutoff of 0.15, yet 50 % patients have no histologic evidence of PCa, whereas prostates
ISSN:0301-1623
1573-2584
DOI:10.1007/s11255-015-1146-2